Ginkgo Bioworks Holdings (DNABW) Revenue (2020 - 2026)

Ginkgo Bioworks Holdings has reported Revenue for 7 years, with the latest figure at $19.5 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 49.06% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $141.3 million (down 37.84% YoY), and the FY2025 full-year result was $170.2 million, down 25.06% from the prior year.
• Revenue for Q1 2026 stood at $19.5 million, down from $33.4 million in the prior quarter.
• The five-year high for Revenue was $168.4 million in Q1 2022, with the low at $19.5 million in Q1 2026.
• Historically, Revenue has averaged $66.8 million across 5 years, with a median of $55.4 million in 2023.
• Annual changes were most pronounced in 2022 — Revenue surged 281.9% — and 2023, when it slumped 64.64%.
• Ginkgo Bioworks Holdings' Revenue stood at $98.3 million in 2022, then tumbled by 64.64% to $34.8 million in 2023, then climbed by 26.16% to $43.8 million in 2024, then slipped by 23.84% to $33.4 million in 2025, then sank by 41.69% to $19.5 million in 2026.
• The last three Revenue figures came in at $19.5 million (Q1 2026), $33.4 million (Q4 2025), and $38.8 million (Q3 2025), per Business Quant data.